At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cooperative Study of The Clinical Course of Sickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated Jun 24, 2005
In Brief
An observational study for Anemia, Sickle Cell and Blood Disease. Completed.
Detailed Summary
To determine the natural history of sickle cell disease from birth to death in order to identify those factors contributing to the morbidity and mortality of the disease.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia, Sickle Cell, Blood Disease
Countries--
Collaborators--
Timeline
N/ACompletedFinished
197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 1977
First PostedMay 2000
Study CompletionDec 2000
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartSep 1, 1977
Study CompletionDec 1, 2000
TodayJul 2, 2026
Posted 26.1 years ago